Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma.
Saved in:
| Title: | Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. |
|---|---|
| Authors: | Chen, Ping1,2 (AUTHOR), Wang, Mengchi2,3 (AUTHOR), Peng, Siyan1,2,3 (AUTHOR), Zhu, Honglin1,2,4 (AUTHOR), Wang, Yanming1,2,5 (AUTHOR), Wan, Zixuan3 (AUTHOR), Yang, Xuan1,4 (AUTHOR), Yu, Zhixin2,5 (AUTHOR), Zhou, Yixin1,2 (AUTHOR) |
| Source: | Current Oncology. Mar2026, Vol. 31 Issue 3, p173. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 192598828 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chen%2C+Ping%22">Chen, Ping</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Mengchi%22">Wang, Mengchi</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Siyan%22">Peng, Siyan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Honglin%22">Zhu, Honglin</searchLink><relatesTo>1,2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yanming%22">Wang, Yanming</searchLink><relatesTo>1,2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wan%2C+Zixuan%22">Wan, Zixuan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Xuan%22">Yang, Xuan</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Zhixin%22">Yu, Zhixin</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Yixin%22">Zhou, Yixin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. Mar2026, Vol. 31 Issue 3, p173. 18p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192598828 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/curroncol33030173 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 173 Titles: – TitleFull: Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen, Ping – PersonEntity: Name: NameFull: Wang, Mengchi – PersonEntity: Name: NameFull: Peng, Siyan – PersonEntity: Name: NameFull: Zhu, Honglin – PersonEntity: Name: NameFull: Wang, Yanming – PersonEntity: Name: NameFull: Wan, Zixuan – PersonEntity: Name: NameFull: Yang, Xuan – PersonEntity: Name: NameFull: Yu, Zhixin – PersonEntity: Name: NameFull: Zhou, Yixin IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 11980052 Numbering: – Type: volume Value: 31 – Type: issue Value: 3 Titles: – TitleFull: Current Oncology Type: main |
| ResultId | 1 |